Fact CheckerSign in

NCT06195943Completed

Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis

Source: ClinicalTrials.gov · Last updated 8 Apr 2026

Brief summary (registry, in English)

This study will be a pilot study to evaluate the feasibility, safety and acceptability of Exercise and Liver FITness (EL-FIT), a mHealth exercise training program previously validated in patients with cirrhosis in patients with nonalcoholic steatohepatitis.

Status (registry)
Completed
Study type
Interventional
Enrollment
17 (actual)
First submitted
15 Dec 2023
Start date
1 Feb 2024
Primary completion date
1 Mar 2026
Lead sponsor
Milton S. Hershey Medical Center
NCT number
NCT06195943

What you commit to

  • Study type: Interventional
  • Participants enrolled: 17
  • From 1 Feb 2024 to the primary completion date, 1 Mar 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Active cardiac symptoms precluding participation in vigorous exercise
  • Cancer that is active
  • Other chronic liver disease (e.g., viral hepatitis)

Other

  • Active or recent participation in exercise training program within the last 90 days
  • Active or recent weight-loss supplement use within the last 90 days (does not include GLP-1 receptor agonist use)
  • Active illicit substance use
  • Cirrhosis
  • Exercise identified to be unsafe by study PI or EL-FIT mHealth program
  • Inability to provide informed consent
  • Inability to walk \> 2 blocks
  • Institutionalized/prisoner

Who the study is looking for

  • Adults age \>18 years
  • Evidence of NASH indicated by at least one of the following
    • Liver biopsy with evidence of steatohepatitis (NAS \>=4) within 6 months of the screening interval or;
    • Historical Imaging study (e.g., ultrasound, CT, MRI) with hepatic steatosis and one of the following non-invasive tests within 6 months of the screening interval: i. FIB-4 \>= 1.3 or; ii. NFS \>= -1.44 or; iii. ELF \>= 7.7 or; iv. VCTE kPa \>=8 or; v. ARFI \>=1.3 or; vi. FAST \>= 0.35 or; vii. MRE kPa \>=2.55 or; viii. MAST \> 0.165 or;
  • Possession of a smartphone

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Penn State Hershey Medical Center
Coordinator of this site? Confirm its status
HersheyUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.